Document text
BioNTech RNA
Pharmaceuticals GmbH
Confidential Interim Clinical Study Report
BNT162 -01 Page 1 of 1
Version: NA
Date: 02 Sep 2020
16.1.4.1 List of investigators
Site number Investigator Site type Site address Site status Deputy investigator (s) at the site
276-01 (Coordinating investigato r &
Principal investigator
Mannheim)
Dr. Dr. med. Armin Schultz Clinical CRO
site CRS Clinical Research Services
Mann heim GmbH
Grenadier Str. 1
68167 Mannheim
Germany
Open Dr. med. Friedeborg Seitz
276-02 (Principal investigator Berlin)
Dr. med. Sybille Baumann Clinical CRO
site CRS Clinical Research Services
Berlin GmbH
Seller Str. 31
13353 Berlin
Germany
Open Dr. med. Matthias Berse,
Manuela Casjens MD
CRO = contract research organization.
090177e194f36bf2\Approved\Approved On: 18-Sep-2020 07:17 (GMT)
Page 1
FDA-CBER-2021-5683-0049318
090177e194f36bec\Approved\Approved On: 18-Sep-2020 07:17 (GMT)
Page 2
(b) (6)
(b) (6)
FDA-CBER-2021-5683-0049319
090177e194f36bec\Approved\Approved On: 18-Sep-2020 07:17 (GMT)
Page 3
FDA-CBER-2021-5683-0049320
090177e194f36bec\Approved\Approved On: 18-Sep-2020 07:17 (GMT)
Page 4
FDA-CBER-2021-5683-0049321
090177e194f36bed\Approved\Approved On: 18-Sep-2020 07:17 (GMT)
Page 5
(b) (6)
(b) (6)
FDA-CBER-2021-5683-0049322
090177e194f36bed\Approved\Approved On: 18-Sep-2020 07:17 (GMT)
Page 6
FDA-CBER-2021-5683-0049323
090177e194f36bee\Approved\Approved On: 18-Sep-2020 07:17 (GMT)
Page 7
(b) (6)
(b) (6)
FDA-CBER-2021-5683-0049324
090177e194f36bee\Approved\Approved On: 18-Sep-2020 07:17 (GMT)
Page 8
FDA-CBER-2021-5683-0049325
090177e194f36bef\Approved\Approved On: 18-Sep-2020 07:17 (GMT)
Page 9
(b) (6)
(b) (6)
FDA-CBER-2021-5683-0049326
090177e194f36bef\Approved\Approved On: 18-Sep-2020 07:17 (GMT)
Page 10
FDA-CBER-2021-5683-0049327
090177e194f36bf0\Approved\Approved On: 18-Sep-2020 07:17 (GMT)
Page 11
(b) (6)
(b) (6)
FDA-CBER-2021-5683-0049328
090177e194f36bf0\Approved\Approved On: 18-Sep-2020 07:17 (GMT)
Page 12
FDA-CBER-2021-5683-0049329
BioNTech RNA
Pharmaceuticals GmbH
Confidential Interim Clinical Study Report
BNT162 -01 Page 1 of 1
Version: 2.0
Date: 26 Nov 2020
16.1.4.3 List of providers
Services provided Name and address (including country)
Medical monitoring Bexon Cinical Consulting, LLC, P.O. Box 3143,
Memorial Station, Upper Montclair, NJ 07043, USA
Trial conduct CRS Clinical Research Services Andernach GmbH
Rennweg 72, 56626 Andernach, Germany (no site, only main office)
Clinical Monitoring Origio Clinical Monitoring GmbH
An den Deichwiesen 21a, Hannover, 30659 Germany
Central laboratory analyses MLM Medical Labs GmbH
Dohrweg 63, D -41066 Moenchengladbach, Germany
Statistics Staburo GmbH, Aschauer Str. 26b, 81549 München, Germany
Pharmacovigilance consultancy activities SCRATCH Pharmacovigilance GmbH & Co. KG
Schlossstrasse 25, D-35510 Butzbach, Germany
PV consultant activities PHARMSOFT Dr. B. Rodust GmbH
Königswall 22, 44137 Dortmund, Germany
Sample processing Precision for Medicine / Epiontis GmbH
Barbara -McClintock - Str. 6, 12489 Berlin, Germany
Specialty analysis VisMederi , Strada del Petriccio e Belriguardo, 35 , 53100 Siena, Italy
Specialty analysis Pfizer Vaccine Research & Development
401 North Middletown Road, Pearl River, NY 10965, USA
Specialty analysis Regeneron Pharmaceuticals
777 Old Saw Mill River Rd, Ta rrytown, NY 10591, USA
Sample processing BioNTech RNA Pharmaceuticals GmbH,
An der Goldgrube 12, 55131 Mainz, Germany
Specialty analysis BioNTech SE,
An der Goldgrube 12, 55131 Mainz, Germany
090177e195a37561\Approved\Approved On: 28-Nov-2020 02:37 (GMT)
Page 13
FDA-CBER-2021-5683-0049330